| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 120,436 | 115,989 | 113,622 | 109,596 | | Cost of Revenue | 32,208 | 31,520 | 31,429 | 30,502 | | | Gross Profit | 88,228 | 84,469 | 82,193 | 79,094 | | | Operating Expenses | | Research Development | 19,568 | 19,836 | 19,717 | 18,605 | | Selling General and Administrative | 56,784 | 58,292 | 58,749 | 54,486 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,822 | 1,821 | 1,821 | 1,822 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,054 | 4,520 | 1,906 | 4,181 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 227 | 85 | 400 | (382) | | Earnings Before Interest And Taxes | 10,281 | 4,605 | 2,306 | 3,799 | | Interest Expense | 227 | 228 | 885 |
-
| | Income Before Tax | 10,054 | 4,377 | 1,421 | 3,799 | | Income Tax Expense | 1,687 | 381 | 4,906 | 2,736 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,367 | 3,996 | (3,485) | 1,063 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,367 | 3,996 | (3,485) | 1,063 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,367 | $3,996 | ($3,485) | $1,063 |
|
0.01% Nasdaq 
Income Statement
